Federated Hermes, Inc. Bluebird Bio, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$1.32 - $4.83 $6,370 - $23,309	4,826 New	4,826 $6,000
Q1 2023 May 08, 2023	SELL	$3.14 - $8.22 $505 - $1,323	-161 Reduced 0.07%	219,700 $698,000
Q4 2022 Feb 13, 2023	SELL	$5.77 - $8.49 $2.26 Million - $3.33 Million	-392,514 Reduced 64.1%	219,861 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $2.04 Million - $4.03 Million	-544,947 Reduced 47.09%	612,375 $3.88 Million
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $707,125 - $1.26 Million	240,519 Added 26.23%	1,157,322 $4.79 Million
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $2.67 Million - $6.96 Million	656,805 Added 252.62%	916,803 $4.45 Million
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $783,041 - $1.43 Million	87,393 Added 50.63%	259,998 $2.6 Million
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $1.94 Million - $3.62 Million	172,605 New	172,605 $3.3 Million
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $276,190 - $564,200	-16,648 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $188,925 - $260,510	6,870 Added 70.26%	16,648 $720,000
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $12,088 - $15,356	-351 Reduced 3.47%	9,778 $528,000
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $139,098 - $235,780	5,129 Added 102.58%	10,129 $618,000
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $177,720 - $234,980	2,000 Added 66.67%	5,000 $730,000
Q2 2018 Aug 10, 2018	SELL	$99.64 - $127.59 $498,200 - $637,950	-5,000 Reduced 62.5%	3,000 $471,000
Q1 2018 May 09, 2018	SELL	$105.8 - $150.94 $2.57 Million - $3.66 Million	-24,247 Reduced 75.19%	8,000 $1.37 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $1.13 Million - $1.81 Million	13,876 Added 75.53%	32,247 $0
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $1.06 Million - $1.68 Million	18,371	18,371 $2.52 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$4.63 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.14 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.4 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.4 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.15 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account